BMC Cancer

1. THOREL L, Divoux J, Lequesne J, Babin G, et al
   The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkers.
   BMC Cancer. 2024;24:701.
   

   >> Share

   
   
2. BENTESTUEN M, Ladekarl M, Knudsen A, Zacho HD, et al
   Diagnostic accuracy and clinical value of [68Ga]Ga-FAPI-46 PET/CT for staging patients with ovarian cancer: study protocol for a prospective clinical trial.
   BMC Cancer. 2024;24:699.
   

   >> Share

   
   
3. DE MORAES FCA, Sudo RYU, Souza MEC, Fernandes MR, et al
   The incidence risk of gynecological cancer by antipsychotic use: a meta-analysis of 50,402 patients.
   BMC Cancer. 2024;24:712.
   

   >> Share

   
   

   
   Br J Cancer

4. ARONSON SL, Walker C, Thijssen B, van de Vijver KK, et al
   Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1).
   Br J Cancer. 2024 Jun 12. doi: 10.1038/s41416-024-02731.
   

   >> Share

   
   
5. QIU L, Li R, Wang Y, Lu Z, et al
   PTEN inhibition enhances sensitivity of ovarian cancer cells to the poly (ADP-ribose) polymerase inhibitor by suppressing the MRE11-RAD50-NBN complex.
   Br J Cancer. 2024 Jun 12. doi: 10.1038/s41416-024-02749.
   

   >> Share

   
   

   
   Cancer

6. 
   Erratum to "Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials".
   Cancer. 2024 Jun 7. doi: 10.1002/cncr.35344.
   

   >> Share

   
   

   
   Cancer Lett

7. YU Y, Lyu C, Li X, Yang L, et al
   Remodeling of tumor microenvironment by extracellular matrix protein 1a differentially regulates ovarian cancer metastasis.
   Cancer Lett. 2024;596:217022.
   

   >> Share

   
   
8. XU J, Lu W, Wei X, Zhang B, et al
   Single-cell transcriptomics reveals the aggressive landscape of high-grade serous carcinoma and therapeutic targets in tumor microenvironment.
   Cancer Lett. 2024;593:216928.
   

   >> Share

   
   

   
   Int J Cancer

9. ALHARBI M, Lai A, Godbole N, Guanzon D, et al
   Enhancing precision targeting of ovarian cancer tumor cells in vivo through extracellular vesicle engineering.
   Int J Cancer. 2024 Jun 7. doi: 10.1002/ijc.35055.
   

   >> Share

   
   

   
   Int J Gynecol Pathol

10. AL-HUSSAINI M, McCluggage WG
    SATB2 Cytoplasmic Expression is Characteristic of a Subset of Ovarian Stromal Cells and Sex Cord Stromal Tumors.
    Int J Gynecol Pathol. 2024;43:373-377.
    

    >> Share

    
    
11. WANG SC, Wu CH, Fu HC, Ou YC, et al
    Estrogen/Progesterone Receptor Expression and Cancer Antigen 125 Level as Preoperative Predictors to Estimate Lymph Node Metastasis in Endometrioid Endometrial Cancer.
    Int J Gynecol Pathol. 2024;43:316-325.
    

    >> Share

    
    
12. GUERRIERO A, Moro M, Angerilli V, Munari G, et al
    Synchronous Endometrial and Ovarian Carcinomas: Pathologic and Molecular Analysis Highlights the Monoclonal Origin of the Lesions.
    Int J Gynecol Pathol. 2024;43:309-315.
    

    >> Share

    
    
13. ZHAO Z, Nadarajah R, Busmanis I
    Synchronous Bilateral Ovarian Mesonephric-like Adenocarcinomas with Separate Origins from High-Grade Mullerian Adenosarcoma and Endometriosis: Report of a Rare Case.
    Int J Gynecol Pathol. 2024;43:382-388.
    

    >> Share

    
    
14. VIKI M, Morrow R
    Metastatic Hepatocellular Carcinoma Represents an Important but Rare Pitfall in the Diagnostic Evaluation of ER Negative Ovarian Malignancy: A Case Report.
    Int J Gynecol Pathol. 2024;43:378-381.
    

    >> Share

    
    
15. GILMORE B, Logan L, McKinnon W, Everett E, et al
    Endometrial Cancer in a Family With RAD51D Gene Mutation.
    Int J Gynecol Pathol. 2024;43:349-353.
    

    >> Share

    
    
16. MIYAMA Y, Ogasawara A, Hasegawa K, Yasuda M, et al
    Premature Classification of Early-stage Endometrioid Ovarian Carcinoma With Mesonephric-like Differentiation as Mesonephric-like Adenocarcinoma.
    Int J Gynecol Pathol. 2024;43:362-372.
    

    >> Share

    
    

    
    Int J Oncol

17. XU S, Zhu C, Xu Q, An Z, et al
    ARID1A restrains EMT and stemness of ovarian cancer cells through the Hippo pathway.
    Int J Oncol. 2024;65:76.
    

    >> Share

    
    

    
    J Natl Cancer Inst

18. BAKER SG, Etzioni R
    Prediagnostic evaluation of multicancer detection tests: design and analysis considerations.
    J Natl Cancer Inst. 2024;116:795-799.
    

    >> Share

    
    

    
    PLoS One

19. KARSTENSEN S, Kaiser K, Moos C, Poulsen TS, et al
    DNA alterations in ovarian adult granulosa cell tumours: A scoping review protocol.
    PLoS One. 2024;19:e0303989.
    

    >> Share

    
    
20. NUNEZ-RIOS JD, Reyna-Jeldes M, Mata-Martinez E, Campos-Contreras ADR, et al
    Extracellular ATP/P2X7 receptor, a regulatory axis of migration in ovarian carcinoma-derived cells.
    PLoS One. 2024;19:e0304062.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share